TY - JOUR
T1 - Haemophilus influenzae disease and immunization in developing countries
AU - Funkhouser, Ann
AU - Steinhoff, Mark C.
PY - 1991/5
Y1 - 1991/5
N2 - Haemophilus influenzae is one of the leading causes of severe bacterial infection in children of developing regions, causing 30% of the cases of culture-positive pneumonia and 20%-60% of the cases of bacterial meningitis. In infants and children, the majority of isolates from cerebrospinal fluid and blood and 16%-38% of pulmonary isolates are H. influenzae type b. The availability of several new polysaccharide-protein conjugate vaccines for the prevention of invasive disease due to H. influenzae type b prompts this review of the epidemiology of H. influenzae disease in the developing world and of the characteristics of current H. influenzae type b vaccines. To develop a strategy for use of H. influenzae type b vaccines in developing countries, the following data are needed: The age-specific attack rates of H. influenzae type b disease and the immunoge- nicity and efficacy of these vaccines in young infants in developing countries. Should H. influenzae type b vaccines prove to be inadequate for the prevention of H. influenzae pneumonia, the use of non-type b H. influenzae vaccines may be necessary.
AB - Haemophilus influenzae is one of the leading causes of severe bacterial infection in children of developing regions, causing 30% of the cases of culture-positive pneumonia and 20%-60% of the cases of bacterial meningitis. In infants and children, the majority of isolates from cerebrospinal fluid and blood and 16%-38% of pulmonary isolates are H. influenzae type b. The availability of several new polysaccharide-protein conjugate vaccines for the prevention of invasive disease due to H. influenzae type b prompts this review of the epidemiology of H. influenzae disease in the developing world and of the characteristics of current H. influenzae type b vaccines. To develop a strategy for use of H. influenzae type b vaccines in developing countries, the following data are needed: The age-specific attack rates of H. influenzae type b disease and the immunoge- nicity and efficacy of these vaccines in young infants in developing countries. Should H. influenzae type b vaccines prove to be inadequate for the prevention of H. influenzae pneumonia, the use of non-type b H. influenzae vaccines may be necessary.
UR - http://www.scopus.com/inward/record.url?scp=0025860730&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025860730&partnerID=8YFLogxK
U2 - 10.1093/clinids/13.Supplement_6.S542
DO - 10.1093/clinids/13.Supplement_6.S542
M3 - Article
C2 - 1862284
AN - SCOPUS:0025860730
SN - 0162-0886
VL - 13
SP - S542-S554
JO - Reviews of infectious diseases
JF - Reviews of infectious diseases
ER -